Lupin Limited (LUPIN.BO)

1,580.05 -0.50 (-0.03%) 收市：03:29PM IST

Lupin Limited

Kalpataru Inspire
3rd Floor Off. Western Expressway Highway Santacruz (East)
Mumbai 400055
India
91 22 6640 2323
https://www.lupin.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 20,933

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Vinita D. Gupta	CEO & Executive Director	109.2M	無	1968
Mr. Ramesh Swaminathan	Global CFO, CRO, Head of Corporate Affairs & Executive Director	66.86M	無	1966
Mr. Nilesh Deshbandhu Gupta	MD & Executive Director	49.6M	無	無
Mr. Johnny Mack Mikell	President & Global Head of Quality	無	無	無
Mr. Christoph Funke	Chief Technical Operations Officer	無	無	無
Mr. Sreeji Gopinathan	Chief Information Officer	無	無	無
Dr. Shahin Fesharaki	Global Chief Scientific Officer	無	無	無
Dr. Hemant Bakhru	Vice President of Investor Relations and M&A	無	無	無
Dr. Sofia Mumtaz	President of Legal and Compliance of Australia, Japan & Canada Business	無	無	無
Ms. Diana Amador-Toro	Senior Vice President of Global Compliance	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 INR。

描述

Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilars; over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

公司管治

截至 2024年4月1日 止，Lupin Limited 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中：10；董事會：4；股東權利：1；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。